Collaborate with peers on clinical care and research related to obesity. The SIG will discuss topics such as the pharmacoeconomics of obesity, funding opportunities, how NuSH-based AOMs are changing obesity treatment, and engaging with multidisciplinary subspecialties to bridge care gaps in obesity-related comorbidities. Participate in obesity education and networking activities, as well as leadership and program development opportunities, including webinars, event meetups, collaborative projects, and more!
Upcoming Joint EDC/Obesity SIG Webinar: Reprogrammed by Chemicals: The Epigenetic Link Between Environmental Exposure and Obesity
Date: February 6, 2026 Time: 11:00 AM ET– 12:30 PM ET
Moderators:
Aldo E. Calogero, MD, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
Rossella Cannarella, MD, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
Speakers:
Furkan M Burak, MD, PhD, Sabri Ülker Center for Metabolic Research, Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Giovanna Muscogiuri, MD, PhD, Department of Clinical Medicine and Surgery, Italian Center for the Care and Well-being of Patients with Obesity (C.I.B.O), University of Naples Federico II, Naples, Italy, Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ, USA.
Andrea Crafa, MD, PhD, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
Oliver J. Rando, MD, PhD, Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Description:
This webinar will explore the emerging role of environmental and epigenetic factors in the development and transgenerational transmission of obesity. Bringing together leading experts in endocrinology, metabolism, and reproductive epigenetics, the event will examine how endocrine-disrupting chemicals and lifestyle-related factors interact with adipose tissue biology and germ cell epigenetics. Particular attention will be given to the impact of environmental exposures and paternal obesity on sperm epigenetic programming and long-term metabolic health across generations. Through an integrated and multidisciplinary perspective, the webinar aims to provide novel insights into the complex mechanisms linking environment, epigenetics, and obesity.
Objectives:
To understand the global burden of obesity and the multifactorial mechanisms underlying its development, including genetic, environmental, and epigenetic contributors.
To examine the obesogenic effects of endocrine-disrupting chemicals on adipocyte biology and metabolic regulation.
To explore how environmental exposures and paternal obesity influence sperm epigenetics and contribute to the transgenerational transmission of obesity risk.
Please note: you must be a member of the SIG to view these webinar recordings.
Past Obesity SIG Webinars
Friday, May 30, 2025 Speaker:
Marcelo Correia MD, MSc, PhD, DABOM; University of Iowa, Division of Endocrinology; VAMC
Description:
To give an overview of diets and dietary strategies to manage obesity, particularly in the setting of potent anti-obesity medicines
Learning Objectives:
Dietary strategies to manage obesity
Discuss different types of diet recommended by professional societies
Discuss dietary strategies for muscle mass preservation during treatment with incretin-based anti-obesity medicines
March 4, 2025
Speaker:
Mehmet Furkan Burak, MD, co-chair of Obesity SIG, Brigham and Women’s Hospital, Harvard Medical School
Description:
In this interactive webinar, Dr. Burak will review the paradigm shift in obesity treatment, review what changed in treatment landscape, and where it's going with pipeline data review.
Learning Objectives:
Objective 1: Understand the current pharmacological options of obesity treatment
Objective 2: Understand the biology of energy regulation and weight management
Objective 3: Review the current data for major obesity treatments in clinical trials.
Collaborate with peers on clinical care and research related to obesity. The SIG will discuss topics such as the pharmacoeconomics of obesity, funding opportunities, how NuSH-based AOMs are changing obesity treatment, and engaging with multidisciplinary subspecialties to bridge care gaps in obesity-related comorbidities. Participate in obesity education and networking activities, as well as leadership and program development opportunities, including webinars, event meetups, collaborative projects, and more! 
